All timeline stories.


It’s Coming…


2006: Revolution in HIV treatment. First EMA approval for single tablet regimen taken once a day

Nominated by: Gilead Sciences Organisation in nomination: Gilead Sciences Antiretroviral therapy (ART) has played an instrumental role in the treatment of HIV, increasing the life expectancy..Read More

2019: Large scale microbial production of next generation, zero-calorie, non-artificial EVERSWEET™ Stevia sweetener

Nominated by: DSM Organisation in nomination: DSM, Cargill Most people consume too many calories that originate from sugar, increasing the risk of being overweight or developing..Read More

1996: Understanding how the immune system recognises virus-infected cells. Nobel Prize for Physiology or Medicine

Nominated by: Swiss Biotech Association Organisations in nomination: Rolf M Zinkernagel, Professor of Experimental Immunology at the University of Zurich    Viruses infect host cells and reproduce inside them...Read More

Improved food safety through asparaginase produced via genetically modified micro-organisms: reduced acrylamide in cooked food

Nominated by: DSM Organisation in nomination: DSM and Novozymes     Acrylamide can arise during the cooking process of foods via reaction of the amino acid asparagine and..Read More

It’s Coming…


2017: First Radioligand therapy (RLT) approved in Europe for the treatment of gastroenteropancreatic neuroendocrine tumours – Lutathera®

Nominated by: Novartis Organisations in nomination: Novartis Gastroenteropancreatic neuroendocrine tumours are a rare type of cancer that can form in the pancreas or in other parts..Read More

2014: First Industrial Fermentation-derived perfume ingredient Clearwood®

Nominated by: Scienceindustries Switzerland  Organisation in nomination: Firmenich  Terpenes are complex natural compounds and important raw materials for the fragrance & flavour and the pharmaceutical industries...Read More

2007: Landmark European publication behind ‘Knowledge Based Bioeconomy’ in Europe

Nominated by: BIO Deutschland Under the German Presidency of the Council of the European Union, 42 experts from academia and industry across 13 countries were invited..Read More

2007: First production of spider silk through biotechnology

Nominated by: BIO Deutschland Organisation in nomination: AMSilk  Spider silk has long been hailed for its properties, the ultimate biomaterial, however production from spiders directly on..Read More

2003: Human Genome Project completion

Nominated by: Voisin Consulting Life Sciences Launched in 1990, the Human Genome project was an unprecedented international scientific research project with the primary goal to discover..Read More

1996: First European Commission-approved product following European Agency for the Evaluation of Medicinal Products (EMEA, later EMA) recommendation

Nominated by: Voisin Consulting Life Sciences Organisation in nomination: European Commission  1996 saw the first legal/regulatory framework for medicinal products in the European Union. GONAL-f from..Read More

2014: Checkpoint inhibitor innovation as key part of cancer immunotherapy

Nominated by: UK BioIndustry Association  Organisation in nomination: LifeArc    (From 2004) US Biotech company Organon’s scientists focused on the discovery of antibodies as therapeutics and..Read More

2016: First curative gene therapy for ADA-SCID approved for infants

Nominated by: Federchimica Assobiotec Organisation in nomination: GlaxoSmithKline (GSK), currently moved to Orchard Therapeutics, Telethon Foundation (Telethon), l’IRCCS San Raffaele Hospital (SRH) Italy and Molecular Medicine SpA..Read More

1996: Introduction of law in Italy for early access to drugs (648/1996) to support rare disease patients

Nominated by: Federchimica Assobiotec  Organisation in nomination: Government of Italy Early access programmes for novel medicines can benefit patients suffering from serious illnesses for which effective..Read More

2006: Globally accessible Gene Sequencing Technology

Nominated by: UK BioIndustry Association  Organisation in nomination: Solexa: Professor Sir Shankar Balasubramanian and Professor Sir David Klenerman Following establishment of UK SME Solexa in 1997, Professor Sir..Read More

1997: First clinical trial with D2E7 (Humira), the first fully human monoclonal antibody approved by the US Food and Drug Administration (FDA)

Nominated by: BIO Deutschland Organisations in nomination: BASF, Abbott, AbbVie, Cambridge Antibody Technology (now MedImmune) Diseases linked to the immune system, such as rheumatoid arthritis were very..Read More

1999: Messenger RNA (mRNA) patented in relation to therapeutic applications

Nominated by: Nominees: Dr Ingmar Hoerr, co-founder CureVac Professor Katalin Karikó, University of Pennsylvania and BioNTech The existence of mRNA was hypothesized early in the days..Read More

2000: Vitamin B2 shifts from chemical synthesis to exclusive biotechnological production in less than 15 years

Nominated by: DSM, BASF    Organisation in nomination: DSM, BASF  Vitamin B2 (riboflavin), is a water-soluble compound, which can be synthesized by plants and microorganisms but..Read More

2001: First enzyme replacement therapy for to treat Fabry disease approved in the European Union, plus world’s largest database of Fabry disease patients

Nominated by: Sanofi Organisation in nomination: Sanofi Genzyme Fabry disease (also Anderson–Fabry) disease, is a rare and heritable genetic disorder. The genetic fault behind the disease..Read More
Become a member